napoli-3: first-line nalirifox in metastatic pancreatic ductal adenocarcinoma
Published 1 year ago • 864 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
6:20
first-line nalirifox shows improvement in os and pfs in metastatic pancreatic cancer
-
4:36
phase i/ii results: first-line nalirifox in patients with pancreatic ductal adenocarcinoma
-
0:40
1l nalirifox in advanced or metastatic pdac
-
1:15
optimizing first line treatment in metastatic pancreatic cancer
-
1:28
nalirifox as frontline therapy for pdac
-
0:52
neo-nal-iri: liposomal irinotecan 5-fu & oxaliplatin in panceratic cancer
-
4:04
recent advances in the management of pancreatic cancer
-
1:43
liposomal irinotecan fluorouracil/leucovorin after progression in mpdac
-
8:07
phase 1/2 study results of liposomal irinotecan and folfox in pancreatic cancer
-
5:39
the napoli-1 trial in pancreatic cancer
-
1:08
the role of neoadjuvant immunotherapy in msi-high gastric cancer
-
0:48
current and future directions in gastric cancer research
-
1:29
dr. ocean on the development of nanoliposomal irinotecan in metastatic pancreatic cancer
-
0:30
ecbv ch 04 pancreas 3 cauda
-
1:41
dr. kundranda on efficacy of liposomal irinotecan in pancreatic cancer
-
1:53
dr. ulahannan on the prodige 35 trial in pancreatic cancer
-
0:31
mucinous cystic neoplasm (mcn)
-
0:46
how will proton therapy impact the treatment landscape of pancreatic cancer?
-
21:03
minimally invasive surgical options for management of pancreaticobiliary malignancy